Healthcare Associated Infection

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ondine Biomedical
Ondine BiomedicalBC - Vancouver
1 program
1
Methylene Blue OnlyPhase 1/21 trial
Active Trials
NCT05797818CompletedEst. Feb 2023
XD
1 program
Pulsed xenon ultravioletN/A1 trial
Active Trials
NCT03349268CompletedEst. Apr 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ondine BiomedicalMethylene Blue Only
Xenex Disinfection ServicesPulsed xenon ultraviolet

Clinical Trials (2)

NCT05797818Ondine BiomedicalMethylene Blue Only

Red Light Photobiomodulation and Topical Disinfectants

Start: Jan 2023Est. completion: Feb 2023
Phase 1/2Completed
NCT03349268Xenex Disinfection ServicesPulsed xenon ultraviolet

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Start: Jul 2017Est. completion: Apr 2020
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space